ESOPApr 17, 2026, 04:06 PM
ALX Oncology Grants 800,000 Stock Options to New CDOO Jeff Knight
AI Summary
ALX Oncology Holdings Inc. announced the grant of an inducement stock option to Jeff Knight, M.P.H., its new Chief Development and Operating Officer. The option covers 800,000 shares of common stock, with an exercise price of $1.68 per share. This grant is intended to incentivize Mr. Knight's employment and vests over time, with 25% vesting after one year and the remainder monthly.
Key Highlights
- Granted 800,000 stock options to Chief Development and Operating Officer.
- Exercise price set at $1.68 per share, equal to closing price on grant date.
- Options vest 25% after one year, then 1/48th monthly thereafter.
- Grant serves as an inducement for new employment.
Price Impact
More from ALXO